Evidence map›Paper›PMID 26132880›Full record

ReviewExpert reviews in molecular medicine2015

Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis.

David E Godler, Yoshimi Inaba, Charles E Schwartz, Quang M Bui, Elva Z Shi, Xin Li, Amy S Herlihy, Cindy Skinner, Randi J Hagerman, David Francis and 4 more

Open access · hybridAbstract readReview
In one paragraph

Review in Expert reviews in molecular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. HeterozygousHeliyon · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Significantly ElevatedInternational journal of molecular sciences · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

David E GodlerCyto-molecular Diagnostic Research Laboratory,Victorian Clinical Genetics Services and Murdoch Children's Research Institute,Royal Children's Hospital,Melbourne,Victoria,3052,Australia.
Yoshimi InabaCyto-molecular Diagnostic Research Laboratory,Victorian Clinical Genetics Services and Murdoch Children's Research Institute,Royal Children's Hospital,Melbourne,Victoria,3052,Australia.
Charles E SchwartzCenter for Molecular Studies,J.C. Self Research Institute of Human Genetics,Greenwood Genetic Center,South CA,USA.
Quang M BuiCentre for Molecular,Environmental,Genetic and Analytic Epidemiology,University of Melbourne,Carlton,Victoria,3053,Australia.
Elva Z ShiCyto-molecular Diagnostic Research Laboratory,Victorian Clinical Genetics Services and Murdoch Children's Research Institute,Royal Children's Hospital,Melbourne,Victoria,3052,Australia.
Xin LiCyto-molecular Diagnostic Research Laboratory,Victorian Clinical Genetics Services and Murdoch Children's Research Institute,Royal Children's Hospital,Melbourne,Victoria,3052,Australia.
Amy S HerlihyPublic Health Genetics,Murdoch Children's Research Institute,Royal Children's Hospital,Melbourne,Victoria,3052,Australia.
Cindy SkinnerCenter for Molecular Studies,J.C. Self Research Institute of Human Genetics,Greenwood Genetic Center,South CA,USA.
Randi J HagermanThe MIND Institute,University of California,Davis Medical Center,Sacramento,CA,USA.
David FrancisCyto-molecular Diagnostic Research Laboratory,Victorian Clinical Genetics Services and Murdoch Children's Research Institute,Royal Children's Hospital,Melbourne,Victoria,3052,Australia.
David J AmorCyto-molecular Diagnostic Research Laboratory,Victorian Clinical Genetics Services and Murdoch Children's Research Institute,Royal Children's Hospital,Melbourne,Victoria,3052,Australia.
Sylvia A MetcalfeDepartment of Paediatrics,University of Melbourne,Melbourne Victoria,3052,Australia.
John L HopperCentre for Molecular,Environmental,Genetic and Analytic Epidemiology,University of Melbourne,Carlton,Victoria,3053,Australia.
Howard R SlaterCyto-molecular Diagnostic Research Laboratory,Victorian Clinical Genetics Services and Murdoch Children's Research Institute,Royal Children's Hospital,Melbourne,Victoria,3052,Australia.
Murdoch Children's Research Institute · AUVictorian Clinical Genetics Services · AUGreenwood Genetic Center · USRoyal Children's Hospital · AUThe University of Melbourne · AUUniversity of California Davis Medical Center · US

Funding

GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
NICHD NIH HHS HD36071
6 · The paper itself

Abstract

Methylation of the fragile X mental retardation 1 (FMR1) exon 1/intron 1 boundary positioned fragile X related epigenetic element 2 (FREE2), reveals skewed X-chromosome inactivation (XCI) in fragile X syndrome full mutation (FM: CGG > 200) females. XCI skewing has been also linked to abnormal X-linked gene expression with the broader clinical impact for sex chromosome aneuploidies (SCAs). In this study, 10 FREE2 CpG sites were targeted using methylation specific quantitative melt analysis (MS-QMA), including 3 sites that could not be analysed with previously used EpiTYPER system. The method was applied for detection of skewed XCI in FM females and in different types of SCA. We tested venous blood and saliva DNA collected from 107 controls (CGG < 40), and 148 FM and 90 SCA individuals. MS-QMA identified: (i) most SCAs if combined with a Y chromosome test; (ii) locus-specific XCI skewing towards the hypomethylated state in FM females; and (iii) skewed XCI towards the hypermethylated state in SCA with 3 or more X chromosomes, and in 5% of the 47,XXY individuals. MS-QMA output also showed significant correlation with the EpiTYPER reference method in FM males and females (P < 0.0001) and SCAs (P < 0.05). In conclusion, we demonstrate use of MS-QMA to quantify skewed XCI in two applications with diagnostic utility.

Indexed as

AneuploidyX Chromosome InactivationAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChromosomes, Human, XCpG IslandsDNADNA MethylationExonsFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeDNAFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID26132880
PMCPMC4836209
OpenAlexW2145271387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.